Background
Methods
Data and study design
Healthcare utilisation, work absenteeism and calculation of costs
Health-related quality of life
Comorbidities
Statistical analysis
Sensitivity analysis
Ethics statement
Results
Characteristics of the study population
Subgroups |
p-value | |||||
---|---|---|---|---|---|---|
A | B | B1 | B2 | A vs. B | B1 vs. B2 | |
N | 2049 | 131 | 106 | 25 | ||
Age (years) | 65.4 (8.2) | 60.3 (10.0) | 59.6 (9.9) | 63.1 (10.2) | <.001a
| .12a
|
% Age < 45 years | 1.0 | 3.8 | 3.8 | 4.0 | <.001b
| .63 b
|
% Age 45–55 years | 9.1 | 29.0 | 30.19 | 24.0 | ||
% Age 56–65 years | 33.6 | 29.8 | 31.1 | 24.0 | ||
% Age 66–75 years | 44.1 | 31.3 | 30.2 | 36.0 | ||
% Age > 75 years | 12.1 | 6.1 | 4.72 | 12.0 | ||
Gender | ||||||
% Males | 61.1 | 56.5 | 62.3 | 32.0 | .30b
| .01b
|
COPD GOLD Grade | .01b
| <.001b
| ||||
% Grade 1 (FEV1% pred. ≥ 80%) | 9.0 | 4.6 | 4.7 | 4.0 | ||
% Grade 2 (50 ≤ FEV1% pred. < 80) | 42.3 | 34.4 | 24.5 | 76.0 | ||
% Grade 3 (30 ≤ FEV1% pred. < 50) | 38.1 | 42.8 | 50.9 | 8.0 | ||
% Grade 4 (FEV1% pred. < 30) | 10.5 | 18.3 | 19.8 | 12.0 | ||
Education | <.001b
| .86b
| ||||
% Basic school education | 57.0 | 32.1 | 33.0 | 28.0 | ||
% Secondary school education | 26.0 | 43.5 | 42.5 | 48.0 | ||
% Higher school education | 17.0 | 24.4 | 24.5 | 24.0 | ||
Smoking status | <.001b
| .25b
| ||||
% Never smokers | 5.4 | 23.7 | 20.8 | 36.0 | ||
% Former smokers | 69.2 | 75.6 | 78.3 | 64.0 | ||
% Smokers | 25.4 | 0.7 | 0.9 | 0.0 | ||
BMI (kg/m2) | 26.8 (5.3) | 24.7 (4.0) | 24.6 (4.1) | 24.8 (3.6) | <.001a
| .85a
|
% Normal weight (18.5 ≤ BMI < 25) | 35.7 | 52.7 | 52.8 | 52.0 | <.001b
| .64b
|
% Overweight (25 ≤ BMI < 30) | 37.1 | 33.6 | 32.1 | 40.0 | ||
% Obese (BMI ≥ 30) | 23.7 | 9.9 | 10.4 | 8.0 | ||
% Underweight (BMI < 18.5) | 3.5 | 3.8 | 4.7 | 0.0 | ||
Comorbidities | ||||||
Count | 3.9 (2.6) | 3.1 (2.5) | 3.0 (2.5) | 3.4 (2.3) | <.001c
| .30c
|
% Liver cirrhosis | 1.3 | 1.5 | 1.9 | 0.0 | .68b
| .49b
|
% Hepatitis | 5.4 | 6.9 | 8.5 | 0.0 | .48b
| .13b
|
Unadjusted healthcare utilisation, work absence and retirement
Healthcare utilization | Subgroups | |||
A | B | B1 | B2 | |
(n = 2049) | (n = 131) | (n = 106) | (n = 25) | |
Outpatient services (3 months) | ||||
General practitioner
| ||||
% User | 76 | 66 | 64 | 76 |
Number of visits | 1.9 (2.3) | 3.8 (4.8) | 4.1 (5.0) | 2.7 (3.7) |
Specialists
| ||||
% User | 94 | 96 | 96 | 96 |
Number of visits | 4.4 (4.4) | 8.9 (7.4) | 9.6 (7.0) | 5.9 (8.5) |
Ambulant hospital visits
| ||||
%User | 16 | 18 | 18 | 16 |
Number of visits | 0.3 (1.5) | 0.7 (3.0) | 0.8 (3.3) | 0.2 (0.4) |
Inpatient services (12 months) | ||||
% User | 39 | 24 | 24 | 24 |
Number of visits | 0.6 (1.1) | 0.3 (0.8) | 0.4 (0.9) | 0.3 (0.5) |
Duration of stay | 5.8 (14.1) | 2.3 (5.8) | 2.2 (5.7) | 2.7 (6.3) |
Rehabilitation (12 months) | ||||
Ambulant
| ||||
% User | 2 | 4 | 3 | 8 |
Number of visits | 0.5 (4.2) | 0.6 (3.1) | 0.5 (2.8) | 1.16 (4.0) |
Stationary
| ||||
% User | 14 | 21 | 22 | 16 |
Duration of stay | 3.3 (8.8) | 5.2 (10.9) | 5.4 (10.6) | 5.0 (12.3) |
Physiotherapist (12 months) | ||||
%User | 35 | 52 | 51 | 56 |
Number of visits | 7.1 (18.5) | 15.2 (23.6) | 15.2 (24.1) | 14.9 (22.1) |
Medication (7 days) | ||||
Number of prescribed medications (without AT) | 6.1 (3.2) | 4.7 (2.7) | 4.7 (2.6) | 4.4 (3.1) |
Direct costs (12 months) | ||||
Outpatient costs | 938 (834) | 2160 (1547) | 2423 (1559) | 1044 (857) |
Inpatient costs | 3441 (8302) | 1341 (3394) | 1285 (3337) | 1579 (3687) |
Rehabilitation | 433 (1086) | 674 (1327) | 675 (1293) | 666 (1487) |
Physiotherapist | 118 (307) | 252 (393) | 253 (400) | 247 (368) |
Medication costs | 2533 (3327) | 1961 (1076) | 2056 (1080) | 1558 (976) |
Medication costs including AT | 2533 (3327) | 60427 (28718) | 74311 (1080) | 1558 (976) |
Total direct costs | 7446 (9836) | 6374 (4535) | 6675 (4202) | 5096 (5655) |
Total direct costs incl. AT | 7446 (9836) | 64840 (29467) | 78930 (4202) | 5096 (5655) |
Indirect costs (participants < 65 years) | Subgroups | |||
A | B | B1 | B2 | |
(n = 897) | (n = 82) | (n = 69) | (n = 13) | |
Work absenteeism (12 months) | ||||
% retired | 47 | 35 | 37 | 23 |
% employed | 38 | 55 | 54 | 62 |
% thereof with sick days (12 months) | 73 | 67 | 59 | 100 |
Number of sick days | 30.8 (50.9) | 24.8 (46.7) | 24.2 (50.1) | 27.6 (28.0) |
Indirect costs (12 months) | ||||
Costs due to sick days (HC) | 5452 (9015) | 4395 (8278) | 4287 (8882) | 4895 (4965) |
Costs due to sick days (FC) | 2541 (2585) | 2161 (2392) | 1935 (2374) | 3208 (2338) |
Premature retirement (HC) | 17508 (18543) | 13129 (17859) | 13989 (18123) | 8568 (16280) |
Total indirect costs (HC) | 19514 (17615) | 15541 (17231) | 16288 (17595) | 11580 (15155) |
Total indirect costs (FC) | 935 (1989) | 1186 (2069) | 1038 (1982) | 1974 (2413) |
Health-related Quality of Life | Subgroups | |||
A | B | B1 | B2 | |
(n = 2049) | (n = 131) | (n = 106) | (n = 25) | |
SGRQ | 44.0 (20.0) | 44.8 (17.2) | 46.6 (16.4) | 37.5 (20.2) |
CAT | 18.3 (7.4) | 18.6 (6.7) | 18.9 (6.6) | 17.2 (7.3) |
EQ-5D-3 L utility | 81.5 (20.7) | 83.2 (19.1) | 83.0 (19.1) | 83.9 (19.4) |
EQ-5D VAS | 56.2 (19.4) | 56.4 (19.0) | 54.4 (18.8) | 63.6 (18.75) |
Association of AATD and AT with direct and indirect costs
Direct costs | Indirect costs | |||||||
---|---|---|---|---|---|---|---|---|
Costs | Total direct costs | Outpatient costs | Inpatient costs | Medication costs | Other costs | HC | FC | |
Group | A | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. |
B1 | 0.95 (0.80 – 1.12) |
2.73 (2.35 – 3.17) |
0.65 (0.45 – 0.94) | 0.90 (0.79 – 1.03) | 1.14 (0.81 – 1.61) | 1.05 (0.79 – 1.39) | 0.94 (0.66 – 1.35) | |
B2 | 0.80 (0.57 – 1.13) | 1.13 (0.84 – 1.51) | 0.79 (0.39 – 1.63) |
0.72 (0.56 – 0.93) | 1.23 (0.65 – 2.34) | 0.67 (0.38 – 1.18) | 1.18 (0.67 – 2.08) |
Adjusted mean annual costs (€) | |||||
Direct costs | Total | Outpatient costs | Inpatient costs | Medication costs | Other costs |
% zero costs | 0% | 0% | 62% | 0% | 56% |
Group | |||||
A | 7460 [7026 – 7924] | 937 [902 – 973] | 3586 [3201 – 4010] | 2522 [2381 – 2663] | 566 [513 – 628] |
B1 | 7117 [6029 – 8392] |
2570 [2256 – 2866]
|
1715 [740 – 3076]
|
2144 [1903 – 2409]
| 777 [529 – 1049] |
B2 | 6099 [4288 – 8256] | 1061 [763 – 1414] | 2338 [561 – 5288] |
1805 [1388 – 2261]
| 876 [319 – 1659] |
Adjusted mean annual costs (€) | |||||
Indirect costs | Human capital approach | Friction costs approach | |||
% zero costs | 26% | 72% | |||
Group | |||||
A | 19,583 [18,451 – 20,803] | 981 [839 – 1138] | |||
B1 | 18,813 [13,632 – 24,716] | 1276 [608 – 2181] | |||
B2 | 16,171 [6194 – 28,316] | 1866 [633 – 3764] |
Comparison of HRQL in the three subgroups
Regression coefficients | |||||
---|---|---|---|---|---|
HRQL | SGRQ | CAT | EQ-5D-3 L utility | EQ-5D VAS | |
Group | A | Ref. | Ref. | Ref. | Ref. |
B1 | 2.68 (−0.82 – 6.19) | 0.66 (−0.73 – 2.04) | −0.55 (−4.45 – 3.35) | −1.58 (−5.23 – 2.07) | |
B2 | −0.64 (−7.53 – 6.24) | 0.60 (−2.09 – 3.31) | −1.67 (−9.34 – 6.00) | 2.14 (−5.01 – 9.30) |